baber/WOPTO huggingface dataset:
Patent AU-2022215287-A1 (AU)
Title: Aminoglycoside derivatives and uses thereof in treating genetic disorders
Inventor: BAASOV TIMOR
IPC: C07H15/23
Filed: 2022-08-12
Abstract: Novel aminoglycosides, represented by Formulae (e.g., a compound of Formula A, B, 
, I*, III or III*, including compounds represented by Formula Ia, I**, I*a, I*b, Ila, III**, III*a 
and, III*b), as defined in the instant specification, designed to exhibit stop codon mutation 
readthrough activity, are provided. Also provided are pharmaceutical compositions containing 
the same, and uses thereof in the treatment of genetic diseases and disorders, such as diseases 
and disorders associated with stop codon mutations.
Patent AU-2022221575-A1 (AU)
Title: Surface distributed damping system for three dimensional interlinked floating objects
Inventor: LAM THANH TRI
IPC: F16H41/02
Filed: 2022-08-27
Abstract: A distributed damping system, which is stretched close to water surface, applied for 
damping and stabilizing a large number of floating objects.
Patent AU-2022224723-A1 (AU)
Title: Systems and methods for controlled drug delivery pumps
Inventor: LAURENCE LAWTON
IPC: A61M5/172
Filed: 2022-08-30
Abstract: Power and control systems for a drug delivery device allow for the activation, control of, and 
communication with the drug delivery device. The power and control system allows for a delay 
between device activation, and optionally needle insertion, and commencing drug delivery.  
The delay may be for a predetermined time. In addition, the power and control system may 
communicate with one or more external sensors and devices. The inputs from the sensors and 
devices may automatically, or on demand, adjust the delivery parameters of the device. The 
power and control systems may control a drive system that delivers a fluid at a variable rate or 
profile, allowing for the delivery to be tailored to maximize the effectiveness of the treatment.
Patent AU-2022233552-A1 (AU)
Title: Network system with sensor configuration model update
Inventor: BANDEIRA LOURENÇO
IPC: H05B47/105
Filed: 2022-03-10
Abstract: Network system comprising a plurality of edge devices (10), e.g. comprising luminaires, said plurality of edge devices being arranged at a plurality of locations, the plurality of edge devices comprising at least a sensor (11), said sensor being configured for obtaining environmental data related to an event in the vicinity of an edge device of the plurality of edge devices, said sensor being set up according to at least one configuration parameter, and a processing means (50) configured to process input data in accordance with a model to derive the at least one configuration parameter of the sensor; wherein the network system is configured to determine an updated model over time and to reset the processing means so as to process input data in accordance with the updated model.
Patent AU-2022249162-A1 (AU)
Title: Real-time streaming of weapon usage information on disconnected networks
Inventor: CANTY MICHAEL JOHN
IPC: F41A1/00
Filed: 2022-04-01
Abstract: A weapon usage monitoring system that monitors information about at least a first weapon and a second weapon includes a mobile networking hub, a first weapon response device, a second weapon response device and an edge compute resource. The mobile networking hub can provide a local area network (LAN). The first weapon response device can have a first sensor that senses first weapon response data about the first weapon. The first weapon response device can communicate the first weapon response data to the mobile networking hub. The second weapon response device can have a second sensor that senses second weapon response data about the second weapon. The second weapon response device can communicate the second weapon response data to the mobile networking hub. An edge compute resource can aggregate the first and second weapon response data from the mobile networking hub into aggregated weapon response data.
Patent AU-2022256209-A1 (AU)
Title: Floating tabletop display
Inventor: URBAN BRUCE
IPC: G07F17/32
Filed: 2022-10-21
Abstract: A tabletop gaming system comprising: a tabletop surface, the table top 
surface comprising a plurality of buttons; a monitor spaced from the tabletop surface 
and angled obliquely with respect to the tabletop surface, wherein the monitor has a 
front, display surface and an opposing back surface, wherein the back surface of the 
monitor extends from an outside edge of the column to an outside edge of the 
monitor; a column extending from the tabletop surface to the back surface of the 
monitor, wherein the column is an extension of the tabletop surface; an input 
mechanism comprising an input aperture spaced a distance above the tabletop surface 
and attached to the column, and wherein the input aperture is oriented obliquely with 
respect to the display surface; and an output mechanism comprising an output 
aperture spaced a distance above the tabletop surface and attached to the column in 
lateral side-by-side relation to the input mechanism, and wherein the output aperture 
is oriented obliquely with respect to the display surface.  
19137857_1 (GHMatters) P108995.AU.2
Patent AU-2022260255-A1 (AU)
Title: Overloading broadcast dwell intervals in unsynchronized channel hopping mesh networks
Inventor: HETT CHRISTOPHER
IPC: H04W84/18
Filed: 2022-04-13
Abstract: A node includes a processor coupled to a wireless transceiver and a memory. The memory includes instructions that can cause the processor to store a broadcast channel hopping timing interval and a broadcast channel hopping sequence, as well as, channel hopping timings and channel hopping sequences for tracked neighbor nodes. The instructions can also cause the processor to determine whether a destination node for a unicast message corresponds to tracked neighbor nodes. Based on a determination that the destination node does not correspond to any tracked neighbor nodes, the processor can determine (i) a broadcast dwell interval based on the broadcast channel hopping timing interval and (ii) a next broadcast channel based on the broadcast channel hopping sequence. Additionally, instructions can cause the processor to transmit the unicast message to the destination node during the broadcast dwell interval.
Patent AU-2022268781-A1 (AU)
Title: Cyclic Compound having Selective Inhibitory Action on KRAS over HRAS and NRAS
Inventor: KAWADA HATSUO
IPC: C07K7/54
Filed: 2022-05-06
Abstract: The present inventors found a cyclic compound and an oligopeptide compound that selectively inhibit KRAS. The present inventors further found an oligopeptide compound and a non-natural amino acid that are useful for producing the cyclic compound. The present inventors furthermore found that the cyclic compound and the oligopeptide compound interact with a KRAS-specific amino acid residue.
Patent AU-2022273692-A1 (AU)
Title: Pharmaceutical composition and method for treatment of acute respiratory distress syndrome (ards) in corona virus disease (covid-19)
Inventor: GULATI ANIL
IPC: A61K31/496
Filed: 2022-05-11
Abstract: A pharmaceutical composition for treating acute respiratory distress syndrome (ARDS), multiple end organ failure and survival in serious and life-threatening condition in patients with coronavirus disease 2019 (COVID-19) including (a) centhaquine; (b) antiviral therapies for SARS-CoV-2 infection (remdesivir, ivermectin, chloroquine, hydroxychloroquine, azythromicyn, tenofovir, emtricitabine, ritonavir, lopinavir, ASC09, favipiravir, danoprevir, angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), recombinant human angotensin-converting enzyme 2 (rhACE2), xiyanping, alpha-interferon, fludase (DAS 181), eicosapentaenoic acid free fatty acid (EPA-FFA), nitric oxide, PUL-042, Pam2CSK4 acetate, agonists of TLR2 TLR6, and TLR9), convalescent plasma, stem cells or their exosomes, immunomodulation and cytokine-targeted therapies (itolizumab, tocilizumab, sarilumab, acalabrutinib, piclidenoson, tradipitant, CD24Fc, emapalumab, anakinra, TJ003234, BLD-2660, blood purification systems, Spectra Optia Apheresis System, corticosteroids) oxygen concentrator and generator, T89, dantonic, plasminogen supplementation, plasminogen activators, alteplase; (c) budesonide, supportive therapies to reduce fever (like acetaminophen or ibuprofen), steroids (dexamethasone, prednisolone), anticoagulants (aspirin, heparin, non-heparin anticoagulants such as argatroban, bivalirudin, danaparoid, fondaparinux or a direct oral anti-coagulant (DOAC), (d) inhaled synthetic surfactant, antibody to endotoxin, interferon-beta- 1 a, IV prostaglandin EL neutrophil elastase inhibitors, nitric oxide and (e) an excipient. A method for preparing the composition for treating acute respiratory distress syndrome, multiple end organ failure and shock symptoms caused by coronaviruses infection, in particular SARS-CoV-2, MERS-CoV and SARS-CoV, using centhaquine and its analogues compound by mechanism of reduction of edema in the lungs, improvement in ratio of arterial partial pressure of oxygen to fraction of inspired oxygen (Pa02ZFi02 or Sp02ZFi02), blood oxygen saturation(Sp02), normalization in respiratory rate, reduction in lung infiltration, improvement in ARDS score, MODS, Ordinal Scale of COVID-19, and better blood flow and oxygenation of tissues.
Patent AU-2022277806-A1 (AU)
Title: Mesenchymal stem cells for use in the treatment of skin defects
Inventor: LUNDGREN ÅKERLUND EVY
IPC: A61K35/28
Filed: 2022-05-20
Abstract: The present invention relates to compositions comprising integrin α10-selectedMesenchymal Stem Cells (MSCs) for use in treatment and/or regeneration of a skin defect.
Patent AU-2022289017-A1 (AU)
Title: Method for treating chronic obstructive pulmonary disease with an st2 antagonist
Inventor: GRIMBALDESTON MICHELE ANNE
IPC: C07K16/28
Filed: 2022-06-10
Abstract: The application describes a method of treating chronic obstructive pulmonary disease (COPD) in a patient comprising administering 476 mg of an ST2 antagonist to the patient on Day 1 of a treatment period. The application also describes methods of treating or preventing frequency of moderate to severe exacerbations in a patient having COPD comprising administering an effective amount of an ST2 5 antagonist to achieve a clinical improvement of at least 10%, at least 20%, at least 21%, at least 22%, at least 25%, at least 30%, at least 35%, at least 40% or at least 45% annualized exacerbation rate reduction than standard of care (SOC).
Patent AU-2022325217-A1 (AU)
Title: Distributed routing controllers for multi-region sdwan
Inventor: THORIA SAMIR
IPC: H04L45/02
Filed: 2022-08-10
Abstract: According to some embodiments, a software defined wide area network (SD-WAN) includes a first region and a second region. The first region includes multiple first routing controllers and multiple first SD-WAN edge routers. The second region includes multiple second routing controllers and multiple second SD-WAN edge routers. Each first SD-WAN edge router of the first region is configured to establish Overlay Management Protocol (OMP) peering connections with the plurality of first routing controllers of the first region but to avoid establishing OMP peering connections with the plurality of second routing controllers of the second region. Each second SD-WAN edge router of the second region is configured to establish OMP peering connections with the plurality of second routing controllers of the second region but to avoid establishing OMP peering connections with the plurality of first routing controllers of the first region.
Patent AU-2023200283-A1 (AU)
Title: Gas liquefaction system and methods
Inventor: KENNEDY DAVID ALLEN
IPC: F25J3/02
Filed: 2023-01-19
Abstract: A liquefaction system that is configured to use a single methane expander to provide 
primary refrigeration duty. The liquefaction system can include a first or main heat exchanger 
and a fluid circuit coupled with the heat exchanger, the fluid circuit configured to circulate a 
process stream derived from an incoming feedstock of natural gas. The fluid circuit can 
comprise a compression circuit, methane expander coupled with the compression circuit and the 
main heat exchanger, a sub-cooling unit coupled with the methane expander, the sub-cooling unit 
configured to form a liquid natural gas (LNG) product from the process stream, and a first 
throttling device interposed between the main heat exchanger and the sub-cooling unit. The first 
throttling device can be configured to expand the process stream to a process pressure that 
corresponds with the suction pressure internal to the compression circuit.
Patent AU-2023201061-A1 (AU)
Title: Systems and methods for volumetric acquisition in a single-sided mri system
Inventor: GOMES MULLER
IPC: A61B5/055
Filed: 2023-02-23
Abstract: A method for performing magnetic resonance imaging is provided. The method includes 
providing a magnetic resonance imaging system comprising: a radio frequency receive system 
comprising a radio frequency receive coil, and a housing, wherein the housing comprises a 
permanent magnet for providing an inhomogeneous permanent gradient field, a radio frequency 
transmit system, and a single-sided gradient coil set. The method also includes placing the 
receive coil proximate a target subject; applying a sequence of chirped pulses via the transmit 
system; applying a multi-slice excitation along the inhomogeneous permanent gradient field; 
applying a plurality of gradient pulses via the gradient coil set orthogonal to the inhomogeneous 
permanent gradient field; acquiring a signal of the target subject via the receive system, wherein 
the signal comprises at least two chirped pulses; and forming a magnetic resonance image of the 
target subject.
Patent AU-2023202414-A1 (AU)
Title: Adaptors and usability features for respiratory assistance systems
Inventor: STANTON JAMES WILLIAM
IPC: A61M16/16
Filed: 2023-04-19
Abstract: A bypass adaptor for a respiratory assistance system, the bypass adaptor configured to enable an 
inspiratory conduit to be connected between a gases source and a patient interface to bypass a 
humidification device, a connector of the inspiratory conduit configured to be connected to an outlet of 
the humidification device but not suitable for connection to an outlet of the gases source, the bypass 
adaptor comprising: an inlet connector configured to be connected to the outlet of the gases source but 
not suitable for connection to the outlet of the humidification device or to the connector of the 
inspiratory conduit; an outlet connector configured to be connected to the connector of the inspiratory 
conduit but not suitable for connection to the outlet of the gases source or to the outlet of the 
humidification device; and a hollow body defining a gas flow path between the inlet connector and the 
outlet connector, wherein the inlet connector is different from the outlet connector in at least one 
physical respect such that the inlet connector includes at least one physical characteristic that enables 
the inlet connector to be connected to the outlet of the gases source but not to the outlet of the 
humidification device or to the connector of the inspiratory conduit, and/or the outlet connector 
includes at least one characteristic that enables the outlet connector to be connected to the connector 
of the inspiratory conduit but not to the outlet of the gases source or to the outlet of the humidification 
device.
WO 2016/204632 PCT/NZ2016/050098 
1/20 
105 
127 121 17 
137 151 153 155 135 103 
101 
109 113 
157 159 it/ 
131 129 
130 zd 
123 
133 /00 
107--, 125 
Figure 1 
155 
109 
129 
Figure 2 
RIl IRRqTITI ITl~ -li4l~T /R ulo 2DR)
Patent AU-2023274190-A1 (AU)
Title: Method and apparatus for reducing energy consumption
Inventor: ANDREW KILLEN
IPC: H04W52/02
Filed: 2023-11-30
Abstract: METHOD AND APPARATUS FOR REDUCING ENERGY CONSUMPTION 
ABSTRACT 
A method and apparatus may include activating, by a network node, power of a global
positioning-system receiver or power of an active antenna of the global-positioning-system 
receiver. The apparatus uses the global-positioning-system receiver to perform synchronization 
of the apparatus. The method may include receiving at least one measurement, wherein the at 
least one measurement comprises real-time, predictive, or historic data. The method may also 
include determining a holdover duration based on the at least one measurement. The holdover 
duration corresponds to a length of time where the power of the global-positioning-system 
receiver or the power of the active antenna is to be turned off. The method may also include 
deactivating the power of the global-positioning-system receiver or the power of the active 
antenna for the holdover duration.  
Fig. 2
2/6 
211 
212 
A 
213 
eC 214 
215 
Fig. 2 )216 
- 217 
NNNN,~J~',N N218 
t 
N, 
4
NNN,,e(perN{4N d 
Fig. 2(a)
3/6 
V ls GPS on? 
N 
41" 
Power OnOGPS 
Active Antenna 
251 
Measureactual 
iewofsky vs 
unobstructedview 252 
of sky 
Measure SAT 
RSSIs 
v 253 
Measure AP 
Location and 
Velocity 
Collect eeal 254 
data that 
influe nces GPS 
signal strengh 
(eg weather 
forecasts) 255 
Predictwhen 
active antenna is 
required 
Calculate re
sarnpling interval 
V 257 
Calculate tirne 
periods where 
active antenna is 258 
required 
Has re
sarnpling 
duration N 
expired? 
Y 
GPS activeant Power Off GPS 
required' N active antenna 
Y 
Fig. 2(b)
Patent WO-2018018111-A1 (WO)
Inventor: DOS SANTOS LEANDRO VIEIRA
IPC: C12N1/22
Filed: 2017-06-26
Abstract: La présente invention concerne une levure industrielle génétiquement modifiée LVY127 avec la voie oxydoréductive de conversion de xylose, des cassettes d'expression génétique, un procédé d'obtention d'éthanol 2G et l'utilisation de la levure LVY127.
Patent WO-2004104376-A1 (WO)
Title: Moteur dote d'une bague d'entrainement
Inventor: CANNATA ANTONIO
IPC: F02B75/32
Filed: 2004-05-20
Abstract: L'invention concerne un moteur alternatif (100) comprenant un ensemble cylindre (120) possédant une paire de pistons solidaires (130) destinée à décrire un mouvement alternatif dans ce dernier, une bague d'entraînement (150) à orbite de rotation entourant sensiblement l'ensemble cylindre (120) et un mécanisme de transfert d'énergie (160) conçu pour accoupler et convertir le mouvement alternatif des pistons (130) en un mouvement de rotation de la bague d'entraînement (150). Le moteur (100) à bague de rotation (150) peut être utilisé en conformité avec des limitations associées aux moteurs classiques possédant un vilebrequin et à la géométrie correspondante, telles qu'une augmentation de la taille du moteur, une génération de couple moins qu'optimale et une usure prématurée de la paroi du cylindre due aux charges de poussée sur les pistons.
Patent WO-2005018356-A1 (WO)
Title: Forearm protecting device
Inventor: GREGOIRE BERNARD
IPC: A41D13/08
Filed: 2004-08-16
Abstract: The invention concerns a forearm protecting device covering the forearms (22), from the base of the elbow (26) to the wrist (24) providing protection against attacks with truncheons, even with bladed weapons in various situations. The device may cover only the cubital part (30) of the forearm which is the vulnerable part. The covering portion (28) is made from composite materials such as: resistant plastic, polycarbon or other lightweight material. The whole device is supported on a wave-absorbing cushion consisting of Kevlar fibers capable of dispersing a shock wave over a larger surface. The covering portion is provided with six longitudinal rods (44) enabling generation of pressures such as in a Yawara type truncheon. The rods have a diameter ranging between 5 and 15 mm depending on the desired degree of protection. The protective device is maintained in the forearm through hook-and-loop type straps (38). The invention also concerns a similar type of device adapted for shin protection.
Patent WO-2007137384-A1 (WO)
Title: Fibre d'armature pour béton
Inventor: DRYA-LISIECKA KRYSTYNA
IPC: B32B5/02
Filed: 2006-05-25
Abstract: L'invention concerne une fibre d'armature (10, 110, 210, 310) adaptée pour armer un matériau liant composite quand une pluralité de fibres sont incrustées dans celui-ci. Dans un mode de réalisation, la fibre (10) comporte un corps allongé (12) ayant un axe longitudinal (x) s'étendant entre une première extrémité et une deuxième extrémité (14, 16), des côtés opposés (18, 20), et une surface supérieure et une surface inférieure (22, 24) chacune s'étendant entre la première extrémité et la deuxième extrémité et les côtés opposés dans un périmètre. Au moins l'une quelconque de la surface supérieure et de la surface inférieure a une partie bord périphérique (28) s'étendant sur tout le périmètre. Au moins une concavité (32) est définie dans le corps allongé. Une ouverture (34) est définie dans la concavité à l'intérieur d'au moins une des surfaces supérieure et inférieure. L'ouverture est entourée par la partie bord périphérique, et la concavité a une surface intérieure courbe (36) qui est accessible uniquement par l'ouverture.
Patent WO-2007000051-A1 (WO)
Title: Boîtier de stockage de disque de données d’archivage
Inventor: LAPOINTE FREDERIC
IPC: B65D85/57
Filed: 2006-06-28
Abstract: Boîtier de stockage pour disque support ayant une surface de réception de données et définissant un trou à l’intérieur de celui-ci. Le boîtier de stockage comprend un plateau pour recevoir le disque support. Le plateau comprend un dispositif de montage de disque pour y monter le disque support autour du trou. Le dispositif de montage de disque est apte à être déplacé entre une position d’engagement du disque et une position de relâchement du disque. Le plateau comprend également au moins un organe de support de disque pour supporter le disque support lorsque le dispositif de montage de disque est déplacé vers la position de relâchement du disque. Le dispositif de montage de disque peut être monté de façon monobloc avec le plateau ou se constituer d’un corps séparé montable sur celui-ci. L’organe de montage de disque peut également inclure l’organe de support de disque. L’organe de support de disque n’est pas déplacé avec l’organe de montage de disque.
Patent WO-2008095275-A1 (WO)
Title: Méthodes de traitement de la démence sénile de type alzheimer
Inventor: GOODENOWE DAYAN
IPC: A61P25/28
Filed: 2007-08-27
Abstract: La présente invention concerne le diagnostic, l'évaluation de risque, la prévention, et le traitement de la démence sénile de type Alzheimer (DSTA). Plus particulièrement, la présente invention concerne la mesure de phospholipides d'éthanolamine dans le sérum humain. Des sous-ensembles de ces molécules sont sensiblement modifiés chez des sujets présentant des dépôts pathologiquement confirmés d'amyloïde β par rapport à des sujets exempts de dépôts d'amyloïde β, et chez des sujets présentant une manifestation clinique de démence en conformité avec un diagnostic de DSTA par rapport à des groupes témoins non déments. La présente invention concerne également le diagnostic de divers stades de la DSTA, la détection précoce et la prévention de symptômes de la DSTA, le traitement de la DSTA, le diagnostic différentiel de la démence non DSTA, et l'identification de cibles moléculaires pour lesquelles des traitements chimiques ou biologiques peuvent être conçus pour une intervention thérapeutique dans la DSTA. La présente invention concerne en outre des méthodes d'utilisation d'un dosage diagnostique moléculaire pour orienter et sélectionner une intervention thérapeutique appropriée pour des sujets atteints de démence. Enfin, la présente invention concerne des petites molécules ou métabolites dont on a observé que l'abondance est significativement différente entre des personnes présentant une manifestation clinique de la DSTA et des patients normaux non déments.